The use ofhybridisation with DNA probes as a tool for detection of gonococci in urogenital specimens has been investigated extensively in recent years. Probes using nucleotide sequences of the pilin gene,' the IgAl protease gene,2 ribosomal RNA"4 and the cryptic plasmid5 have been reported. The pilin genes of the gonococci have more than one copy, but they are highly homologous with those of the meningococci. All Specimen processing for DNA amplification Bacterial DNA from N gonorrhoeae strains, other Neisseria species, and genital commensals was extracted as described below. A bacterial suspension in water was made from an overnight cultured plate to give about 10' cfu/ml.
Of the bacterial suspension, 50 p1 was used for each extraction and the following reagents were added sequentially to the suspension giving a final concentration of 1 M NaCl, 1 M NaOH and 1% sodium dodecyl sulphate. The contents were mixed and boiled for one minute, then neutralized with two volumes of 1 M TRI S pH 7. The DNA was extracted once with phenol-TRIS, once with phenol-chloroform, and then precipitated with ethanol. The extracted DNA was resuspended in 30 M1 of sterile distilled water or TRIS-EDTA. For clinical specimens from China, each was suspended in 2 ml phosphate buffered saline and vortexed for one minute to release the material from swab. The swab was removed and the suspension centrifuged for five minutes at 2-3000 rev/min to pellet cells. After removing the supernatant by aspiration, the cells were resuspended in 100 p1 1 x PCR buffer with non-ionic detergent Tween 20 0-45% and proteinase K (200 pg/ml). The cell suspension was incubated at 50-60°C for one hour, then heated to 95°C for ten minutes to inactivate the proteinase K.
Selection of PCR primers Sequence data on the cppB gene carried on both the chromosome and the 4-2 kb cryptic plasmid of N gonorrhoeae was used to select two 20-mer oligonucleotide primers designated HOl (5'GCTACGCATACCCGCGTTGC3') and H03 (5'CGAAGACG1TCGAGCAGACA3). The expected length of the amplified product of the target sequence with these primers was 390 bp. It was known from the restriction map of the target sequence that the restriction enzyme MspI would cut within the amplified product to give two fragments of 250 and 140 bp respectively and so it was used to confirm the specificity of the amplified product.
PCR amplification Amplification was performed in 100 p1 reaction volumes containing: 50 pmol of each oligonucleotide primer (HOl and H03) ; 200 pM each of dATP, dCTP, dTTP, and dGTP; 1 x PCR reaction buffer (50 mM KCl, 10 mM TRIS pH 8-3, 100 pg/ml bovine serum albumin, 1-5 mM MgCl2); and a 10 p1 volume ofDNA. For DNA from clinical swabs, 50 p1 of proteinase K treated suspension was used and a 100 p1 reaction volume was made up with the same constituent as described for DNA from bacteria. The tubes were mixed before overlaying with a drop of mineral oil. Forty cycles of amplification were performed in a DNA thermal cycler (Perkin-Elmer Cetus). Each cycle consisted of a 30 second denaturation step at 94°C, a one minute annealing step at 55°C, and a 30 second extension step at 74°C.
Amplified product (10 p1) was analysed by electrophoresis in a 2% agarose gel using standard methods." The 
Results
To evaluate the specificity of the selected primers (HO1 and H03), DNA was extracted from 12 non-gonococcal Neisseria species, 18 genital commensal strains and 33 N gonorrhoeae strains (table 1) . After a 40-cycle PCR reaction, only N gonorrhoeae DNA was amplified (fig 1) to give a product of the expected fragment size (390 bp). N denitrificans DNA also gave an amplified product, but the size was about 190 bp (fig 2) . Apart from N denitrificans, none of the non-gonococcal specificity of 88-9% respectively. Digestion of the PCR amplified product with MspI yielded fragments of the predicted sizes. Discussion Selection of two primers which will amplify a specific sequence of the organism is a crucial step in the success of the PCR assay. In the present study we targeted the cppB gene since a separate copy was present in the genome of all N gonorrhoeae strains tested. The cppB gene originates from the 4-2 kb cryptic plasmid ofN gonorrhoeae which was found in whole or part, integrated in the chromosome of all gonococcal strains tested.7 There are two variants of the cryptic plasmid, one had a deletion of 54 bp within the cppB gene. Both the deleted and the undeleted version of the cppB gene may be found as a separate copy in the gonococcal genome, including the strains lacking plasmid. Therefore, when selecting for the primer sequence, the possibly deleted region of cppB gene was not included in the amplified region and the two chosen 20-mer oligonucleotide primers almost marked the entire length of the remaining cppB gene sequence.
For confirmation of the specificity of the amplified product, the presence of a restriction site within the amplified sequence was shown. This protocol was used instead of Southern hybridisation with a specific probe because of the possibility of clinical application of this assay and the use of hybridisation for confirmation may lengthen the time for diagnosis by another day.
Optimal conditions for the PCR were determined using crude DNA extracted from serial dilutions of gonococcal culture and it was shown that sensitivity of the assay was 500 cfu of N gonorrhoeae. Using the cryptic-derived DNA probe, Torres et al demonstrated a similar sensitivity of 500 cfu.'0 Sensitivity of the PCR assay can be further increased if the method of detection is by probe hybridisation instead of visualisation with the ethidium bromide stained gel.
The specificity test for the chosen primers indicated that the assay would only give a fragment of expected size with N gonorrhoeae. Although the cryptic plasmid of Ngonorrhoeae cross-reacts with plasmids from N meningitidis and N lactamica, this was not detected with our PCR assay. However, only one strain of each species was tested. There was no cross-reaction with any of the non-gonococcal Neisseria strains or other genital flora tested.
For application of this assay to clinical samples, only urethral swabs and cervical swabs have so far been tested. Using culture as the "gold standard", the sensitivity, specificity, PPV, and NPV for this test would be 100, 88-9, 94, and 100% respectively (table 2). The 'gold This cppB gene sequence was chosen as primer due to its presence even on the chromosome ofplasmid-free strains, thus overcoming the limitation of using cryptic plasmid as probe in DNA hybridisation for diagnosis of gonococcal infection. In this study, we were unable to test this hypothesis as plasmid-free strains have so far not been encountered in Asia'3 and we have failed to obtain plasmid-free strains from other workers. We are thus unable to say that this PCR assay is universal for all gonococci. More plasmid-free strains will have to be tested with this assay before it can be used as a reliable diagnostic tool, but our results are promising. It should be investigated whether this PCR method is more useful than the existing enzyme immunoassay (Gonozyme, Abbott Laboratories) or other DNA probes in the accurate assessment of asymptomatic and symptomatic gonococcal infections.
Frozen swabs were used and also swabs which had been stored frozen for one month, and the PCR result was not affected. With the durability of DNA under such conditions, it is possible for specimens to be sent to distant laboratories for investigation. This would be particularly useful for underdeveloped countries or for small laboratories with insufficient facilities.
With the recent development of the PCR, more sensitive DNA probes have been produced and used to detect many of the common agents of sexually transmitted disease, namely Chlamydia trachomatis,"4 human papillomavirus,'5 hepatitis B virus,"6 human immunodeficiency virus,"7 Mycoplasma genitalium819 and Treponema pallidum.' Publication of primer sequences and the evaluation of primers for these organisms could result in multiple probing systems which can be used to determine the full clinical spectrum of the different genital pathogens. As with other noncultural methods the significance of positive results must be carefully assessed in relation to the activity or otherwise of the indicated organism.
